Hindsight Media
Subscribe

AbbVieABBV

HealthcareNYSEFinancial year ends in December

A drugmaker whose medicines include Skyrizi and Rinvoq for immune diseases, and Botox; its former top seller, Humira, now competes with cheaper copies.

Filings to the SEC

FilingPeriodFiled
Quarterly report 10-Q30 September 20263 November 2026
Announcement 8-K: Directors or officers2 November 2026
Announcement 8-K: Results30 October 2026
Announcement 8-K: Directors or officers15 October 2026
Announcement 8-K: Results5 October 2026
Announcement 8-K: Regulation FD disclosure3 September 2026
Announcement 8-K: Other events18 August 2026
Announcement 8-K: Other events5 August 2026
Quarterly report 10-Q30 June 20263 August 2026
Announcement 8-K: Results31 July 2026
Announcement 8-K: Results6 July 2026
Announcement 8-K: Regulation FD disclosure22 June 2026
Announcement 8-K: Shareholder vote12 May 2026
Quarterly report 10-Q31 March 20268 May 2026
Announcement 8-K: Results29 April 2026
Announcement 8-K: Results3 April 2026
Announcement 8-K: Other events4 March 2026
Announcement 8-K: Other events26 February 2026
Annual report 10-K31 December 202520 February 2026
Announcement 8-K: Results4 February 2026
Announcement 8-K: Results7 January 2026
Quarterly report 10-Q30 September 20254 November 2025
Announcement 8-K: Results31 October 2025
Announcement 8-K: Results3 October 2025
Announcement 8-K: Regulation FD disclosure11 September 2025
Quarterly report 10-Q30 June 20254 August 2025
Announcement 8-K: Results31 July 2025
Announcement 8-K: Results3 July 2025
Announcement 8-K: Directors or officers, Shareholder vote13 May 2025
Quarterly report 10-Q31 March 20259 May 2025
Announcement 8-K: Results25 April 2025
Announcement 8-K: Results3 April 2025
Announcement 8-K: Other events26 February 2025
Announcement 8-K: Other events19 February 2025
Annual report 10-K31 December 202414 February 2025
Announcement 8-K: Directors or officers, Regulation FD disclosure14 February 2025
Announcement 8-K: Other events5 February 2025
Announcement 8-K: Results31 January 2025
Announcement 8-K: Impairment10 January 2025
Announcement 8-K: Results6 January 2025

The most recent 40. Every filing is on the SEC’s website.

Charts and live prices are delayed, from TradingView. Market values use each company’s last trade on IEX at the previous close, times the shares in issue from its filings; company figures come from SEC filings. This is information, not investment advice. Where our market data comes from

Company logos are trademarks of their owners, shown only to identify them; the files are from Wikimedia Commons.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.